Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS) Investor Investigation Concerning Potential Securities Laws Violations Announced

If you purchased shares of Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS), you have certain options and you should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this investigation, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
Fresenius Medical Care
Affected Securities: 
NYSE: FMS

January 17, 2017 (Shareholders Foundation) - An investigation on behalf of investors of Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS) shares over potential securities laws violations by Fresenius Medical Care AG & Co. and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS) concerning whether a series of statements by Fresenius Medical Care AG & Co. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Fresenius Medical Care AG & Co. reported that its annual Total Revenue rose from over $15.83 billion in 2014 to over $16.73 billion in 2015 and that its Net Income declined from over $1.04 billion in 2014 to over $1.02 billion in 2015.

Shares of Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS) reached as high as $47.09 per share in August 2016.

On January 7, 2017, Fresenius Medical Care AG & Co. reported that its U.S. unit had received subpoenas from federal prosecutors seeking information on the Company's ties with the American Kidney Fund, a charity that helps patients pay for kidney dialysis.

Shares of Fresenius Medical Care AG & Co. (ADR) (NYSE:FMS) closed on January 17, 2017 at $40.93 per share.